These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Antagonists of group I metabotropic glutamate receptors and cortical afterdischarges in immature rats. Lojková-Janecková D; Ng J; Mares P Epilepsia; 2009 Sep; 50(9):2123-9. PubMed ID: 19486355 [TBL] [Abstract][Full Text] [Related]
3. Age-dependent anticonvulsant action of antagonists of group I glutamate metabotropic receptors in rats. Mares P Epilepsy Res; 2009 Feb; 83(2-3):215-23. PubMed ID: 19097860 [TBL] [Abstract][Full Text] [Related]
4. mGluR5 antagonist-induced psychoactive properties: MTEP drug discrimination, a pharmacologically selective non-NMDA effect with apparent lack of reinforcing properties. Swedberg MD; Ellgren M; Raboisson P J Pharmacol Exp Ther; 2014 Apr; 349(1):155-64. PubMed ID: 24472725 [TBL] [Abstract][Full Text] [Related]
5. Anticonvulsant action of an antagonist of metabotropic glutamate receptors mGluR5 MPEP in immature rats. Lojková D; Mares P Neuropharmacology; 2005; 49 Suppl 1():219-29. PubMed ID: 15950993 [TBL] [Abstract][Full Text] [Related]
6. Metabotropic glutamate receptors as a target for anticonvulsant and anxiolytic action in immature rats. Mares P; Mikulecká A; Tichá K; Lojková-Janecková D; Kubová H Epilepsia; 2010 Jul; 51 Suppl 3():24-6. PubMed ID: 20618395 [TBL] [Abstract][Full Text] [Related]
7. MTEP, a Selective mGluR5 Antagonist, Had a Neuroprotective Effect but Did Not Prevent the Development of Spontaneous Recurrent Seizures and Behavioral Comorbidities in the Rat Lithium-Pilocarpine Model of Epilepsy. Dyomina AV; Kovalenko AA; Zakharova MV; Postnikova TY; Griflyuk AV; Smolensky IV; Antonova IV; Zaitsev AV Int J Mol Sci; 2022 Jan; 23(1):. PubMed ID: 35008924 [TBL] [Abstract][Full Text] [Related]
8. Neuroprotective potential of mGluR5 antagonist MTEP: effects on kainate-induced excitotoxicity in the rat hippocampus. Domin H; Zięba B; Gołembiowska K; Kowalska M; Dziubina A; Śmiałowska M Pharmacol Rep; 2010; 62(6):1051-61. PubMed ID: 21273662 [TBL] [Abstract][Full Text] [Related]
9. AZD9272 and AZD2066: selective and highly central nervous system penetrant mGluR5 antagonists characterized by their discriminative effects. Swedberg MD; Raboisson P J Pharmacol Exp Ther; 2014 Aug; 350(2):212-22. PubMed ID: 24876235 [TBL] [Abstract][Full Text] [Related]
10. Behavioral consequences of co-administration of MTEP and the COX-2 inhibitor NS398 in mice. Part 2. Stachowicz K; Sowa-Kućma M; Pańczyszyn-Trzewik P; Misztak P; Marciniak M; Bobula B; Tokarski K Neurosci Lett; 2021 Jan; 741():135435. PubMed ID: 33171212 [TBL] [Abstract][Full Text] [Related]
11. Microinjection of the mGluR5 antagonist MTEP into the nucleus accumbens attenuates the acquisition but not expression of morphine-induced conditioned place preference in rats. Roohi N; Sarihi A; Shahidi S; Zarei M; Haghparast A Pharmacol Biochem Behav; 2014 Nov; 126():109-15. PubMed ID: 25284131 [TBL] [Abstract][Full Text] [Related]
12. Effect of metabotropic glutamate 5 receptor antagonists on morphine efficacy and tolerance in rats with neuropathic pain. Zhou Q; Wang J; Zhang X; Zeng L; Wang L; Jiang W Eur J Pharmacol; 2013 Oct; 718(1-3):17-23. PubMed ID: 24041921 [TBL] [Abstract][Full Text] [Related]
13. The role of mGluR5 on the therapeutic effects of ketamine in Wistar rats. Gokalp D; Unal G Psychopharmacology (Berl); 2024 Jul; 241(7):1399-1415. PubMed ID: 38459971 [TBL] [Abstract][Full Text] [Related]
14. Neuroprotective activity of the mGluR5 antagonists MPEP and MTEP against acute excitotoxicity differs and does not reflect actions at mGluR5 receptors. Lea PM; Movsesyan VA; Faden AI Br J Pharmacol; 2005 Jun; 145(4):527-34. PubMed ID: 15821750 [TBL] [Abstract][Full Text] [Related]
15. Effects of blocking mGluR5 on primate dorsolateral prefrontal cortical neuronal firing and working memory performance. Yang ST; Wang M; Galvin V; Yang Y; Arnsten AFT Psychopharmacology (Berl); 2021 Jan; 238(1):97-106. PubMed ID: 32939596 [TBL] [Abstract][Full Text] [Related]
16. Involvement of mGlu5 receptor in 3-nitropropionic acid-induced oxidative stress in rat striatum. Souza LC; Wilhelm EA; Bortolatto CF; Nogueira CW; Boeira SP; Jesse CR Neurol Res; 2014 Sep; 36(9):833-40. PubMed ID: 24588139 [TBL] [Abstract][Full Text] [Related]
17. The antinociceptive and anxiolytic-like effects of the metabotropic glutamate receptor 5 (mGluR5) antagonists, MPEP and MTEP, and the mGluR1 antagonist, LY456236, in rodents: a comparison of efficacy and side-effect profiles. Varty GB; Grilli M; Forlani A; Fredduzzi S; Grzelak ME; Guthrie DH; Hodgson RA; Lu SX; Nicolussi E; Pond AJ; Parker EM; Hunter JC; Higgins GA; Reggiani A; Bertorelli R Psychopharmacology (Berl); 2005 Apr; 179(1):207-17. PubMed ID: 15682298 [TBL] [Abstract][Full Text] [Related]
18. The selective mGlu5 receptor antagonist MTEP, similar to NMDA receptor antagonists, induces social isolation in rats. Koros E; Rosenbrock H; Birk G; Weiss C; Sams-Dodd F Neuropsychopharmacology; 2007 Mar; 32(3):562-76. PubMed ID: 16794564 [TBL] [Abstract][Full Text] [Related]
19. mGlu1 and mGlu5 receptor antagonists lack anticonvulsant efficacy in rodent models of difficult-to-treat partial epilepsy. Löscher W; Dekundy A; Nagel J; Danysz W; Parsons CG; Potschka H Neuropharmacology; 2006 Jun; 50(8):1006-15. PubMed ID: 16563443 [TBL] [Abstract][Full Text] [Related]
20. Metabotropic glutamate receptor mGlu5 is a mediator of appetite and energy balance in rats and mice. Bradbury MJ; Campbell U; Giracello D; Chapman D; King C; Tehrani L; Cosford ND; Anderson J; Varney MA; Strack AM J Pharmacol Exp Ther; 2005 Apr; 313(1):395-402. PubMed ID: 15590770 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]